Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Jan;51(1):100-9.
doi: 10.1093/rheumatology/ker280. Epub 2011 Oct 29.

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

Affiliations
Meta-Analysis

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

Gunnar Tomasson et al. Rheumatology (Oxford). 2012 Jan.

Abstract

Objective: The value of repeated ANCA measurements among patients with an established diagnosis of ANCA-associated vasculitis (AAV) remains controversial. The aim of this study was to explore whether either of the two distinct patterns of ANCA values during remission, a rise in ANCA or persistently positive ANCA, predicted future relapse.

Methods: MEDLINE and EMBASE searches were performed. Studies with at least 10 subjects with AAV from which both sensitivity and specificity of a rise in ANCA and/or persistent ANCA for future disease relapse could be calculated were included. Likelihood ratios were calculated for each study and pooled to arrive at summary estimates. I(2)-values were calculated as a measure of heterogeneity and meta-regression was used to explore sources of heterogeneity.

Results: Nine articles on a rise in ANCA and nine articles on persistent ANCA were included. The summary estimates for positive likelihood ratio (LR(+)) and negative likelihood ratio (LR(-)) of a rise in ANCA during remission on subsequent relapse of disease were 2.84 (95% CI 1.65, 4.90) and 0.49 (95% CI 0.27, 0.87), respectively. The summary estimates for LR(+) and LR(-) of persistent ANCA during remission for subsequent disease relapse were 1.97 (95% CI 1.43, 2.70) and 0.73 (95% CI 0.50, 1.06), respectively. There was substantial between-study heterogeneity, which was partially explained by the frequency of ANCA measurements.

Conclusion: Among patients with AAV, a rise in or persistence of ANCA during remission is only modestly predictive of future disease relapse. There is limited use to serial ANCA measurements during disease remission to guide treatment decisions for individual patients with AAV.

PubMed Disclaimer

Figures

F<sc>ig</sc>. 1
Fig. 1
Study flow diagram.
F<sc>ig</sc>. 2
Fig. 2
Forest plots. Forest plots of the LR+ and LR of the nine included studies for the predictability of a rise (A) and of persistence (B) in ANCA on future relapse of disease along with summary estimate (♦) from a random-effects analysis.
F<sc>ig</sc>. 3
Fig. 3
Summary receiver operator curves. HSROC for a rise in ANCA (A) and for persistent ANCA (B) as predictor of relapse. Open circles represent individual studies and the size of the circles represents the inverse variance (precision). Closed circles represent the summary estimate for sensitivity and specificity. The curves are a product of statistical modelling across the whole spectrum of sensitivity and specificity (broken line), but should only be interpreted at the range where they are supported by data (solid line).

References

    1. Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol. 2001;28:1584–90. - PubMed
    1. Finkielman JD, Lee AS, Hummel AM, et al. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007;120:643e9–14. - PubMed
    1. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for ANCA assay standardization. Kidney Int. 1998;53:743–53. - PubMed
    1. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521–37. - PubMed
    1. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med. 1997;126:866–73. - PubMed

Publication types

MeSH terms

Substances